Centre for Cancer Biomarkers CCBIO

CCBIO Research School

Clinical Trials in Cancer Research

New course in the portfolio of the CCBIO Research School of Cancer Studies.

Doctors discussing a medical case.

Course title: "Clinical Trials in Cancer Research"

Responsible for the course: Line Bjørge and Hani Gabra.

Date: October 3 and 4, 2019

Registration: Registration link will be available at a later point.

Preparing participants to conduct clinical trials

Clinical trials are studies performed in humans aimed at evaluating one or more medical surgical or behavioral intervention(s), and trials are the primary method to determine whether a new treatment is safe and effective. Most often a clinical cancer trial compare the most effective known treatment for a specific type or stage of cancer with a new approach although other designs are used more and more. Today clinical trials for almost every type of cancer and the numbers are increasing. While many trials focus on late stage disease there are also trials for cancer prevention and early diagnosis, and prevention of recurrence and survivorship.

The course will consist of 6 different modules. First day will cover:

  • General principles 
  • Operations
  • Formalities
  • Regulations

The second day will focus on: 

  • Success factors
  • Clinical trials in the future

The course is designed to prepare the participants to conduct clinical trials in humans. The modules included will be based on the ICH_GCP, and the participants will receive a certificate in Good Clinical Practice on completion of the course.

The course will be led by Professor and Associated Investigator Line Bjørge at the Centre for Cancer Biomarkers CCBIO and Professor and CCBIO International Affiliated Investigator Hani Gabra, Imperial College of London, London and AstraZeneca, Cambridge, UK.

The course is not applicable for ECTS.